help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 65, No. 3 551-554
doi:10.1210/jcem-65-3-551
Copyright © 1987 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COUCH, R. M.
Right arrow Articles by WINTER, J. S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COUCH, R. M.
Right arrow Articles by WINTER, J. S. D.

Kinetic Analysis of Inhibition of Human Adrenal Steroidogenesis by Ketoconazole*

R. M. COUCH, J. MULLER, Y. S. PERRY and J. S. D. WINTER

Department of Pediatrics, University of Manitoba, and the Children's Hospital Winnipeg, Manitoba, Canada

Address requests for reprints to: Dr. J. S. D. Winter, Children's Hospital of Winnipeg, 840 Sherbrook Street, Winnipeg, Manitoba, R3A 1S1 Canada.

The kinetics of the inhibitory effects of the imidazole antimicrobial ketoconazole on the activities of the steroidogenic enzymes distal to cholesterol side-chain cleavage were studied in human adrenal microsomal and mitochondrial suspensions. Although ketoconazole was a competitive inhibitor of all five enzyme reactions, the effects on 17-hydroxylase, 17,20-desmolase, and 11-hydroxylase activities (Ki = 10–8 M) were considerably greater than those on 21-hydroxylase and 3β-hydroxysteroid dehydrogenase/isomerase activities (Ki = 10–4 M). These findings explain the clinical endocrine effects of ketoconazole in the usual therapeutic doses, which include inhibition of cortisol and androgen secretion, compensatory ACTH-mediated secretion of 17-desoxysteroids such as progesterone and aldosterone, and suppression of PRA.

* This work was supported by grants from the Medical Research Council of Canada, the Children's Hospital of Winnipeg Research Foundation, the St. Boniface Hospital Research Foundation, and the Danish Medical Research Foundation.

Received January 21, 1987.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Venturoli, O. Marescalchi, F. M. Colombo, S. Macrelli, B. Ravaioli, A. Bagnoli, R. Paradisi, and C. Flamigni
A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1304 - 1310.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society